Researcher
Hylke de Jonge
- Disciplines:Urology and nephrology
Affiliations
- Nephrology and Renal Transplantation Research Group (Division)
Member
From1 Oct 2006 → 30 Sep 2010
Publications
1 - 10 of 18
- A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients(2010)
Authors: Dirk Kuypers, Hylke de Jonge, Maarten Naesens, Yves Vanrenterghem
Pages: 2012 - 2023 - Apparent elevation of cyclosporine whole blood concentrations in a renal allograft recipient(2010)
Authors: Hylke de Jonge, Peter Declercq, Kathleen Claes, Dirk Kuypers
Pages: 529 - 531 - Reduced C-0 Concentrations and Increased Dose Requirements in Renal Allograft Recipients Converted to the Novel Once-Daily Tacrolimus Formulation(2010)
Authors: Hylke de Jonge, Kristin Verbeke, Yves Vanrenterghem
Pages: 523 - 529 - Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients(2010)
Authors: Dirk Kuypers, Maarten Naesens, Hylke de Jonge, Evelyne Lerut, Kristin Verbeke, Yves Vanrenterghem
Pages: 394 - 404 - ANTI-REJECTION THERAPY WITH HIGH DOSES OF METHYLPREDNISOLONE INDUCES IN VIVO CYP3A4/5-ACTIVITY IN RENAL TRANSPLANT RECIPIENTS, HOWEVER WITH LIMITED IMPACT ON CALCINEURIN INHIBITOR PHARMACOKINETICS(2010)
Authors: Hylke de Jonge, Jetty De Loor, Kristin Verbeke, Yves Vanrenterghem, Dirk Kuypers
Pages: S25 - S25 - Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts(2009)
Authors: Maarten Naesens, Evelyne Lerut, Hylke de Jonge, Boudewijn Van Damme, Yves Vanrenterghem, Dirk Kuypers
Pages: 2468 - 2480 - THE EFFECT OF HIGH DOSE METHYLPREDNISOLONE THERAPY ON IN VIVO CYP3A4/5 ACTIVITY AND CALCINEURIN INHIBITOR PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS: A PILOT STUDY(2009)
Authors: Hylke de Jonge, Henriette de Loor, Kristin Verbeke, Yves Vanrenterghem, Dirk Kuypers
Pages: 118 - 119 - In vivo cyp3a4/5 activity is significantly higher in tacrolimus treated vs. cyclosporine treated renal transplant recipients three months after transplantation(2009)
Authors: Hylke de Jonge, Henriette de Loor, Kristin Verbeke, Yves Vanrenterghem, Dirk Kuypers
Pages: 119 - 119 - New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation(2009)
Authors: Hylke de Jonge, Maarten Naesens, Dirk Kuypers
Pages: 416 - 435 - Calcium Metabolism in the Early Posttransplantation Period(2009)
Authors: Pieter Evenepoel, Maarten Naesens, Hylke de Jonge, Bert Bammens, Kathleen Claes, Dirk Kuypers, Yves Vanrenterghem
Pages: 665 - 672